Skip to main content
David Klonoff, MD, Endocrinology, Burlingame, CA

David C. Klonoff MD FACP, FRCP (Edin), Fellow AIMBE

Diabetes, Lipid Metabolism


Clinical Professor of Medicine, UCSF

Join to View Full Profile
  • 533 Airport Blvd.Suite #400Burlingame, CA 94010

  • Phone+1 650-218-1142

Dr. Klonoff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1981
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1978 - 1979
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1976 - 1978
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1976
  • University of California, Berkeley
    University of California, BerkeleyBS, Genetics, With Highest Honors, 1968 - 1972

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1977 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Conformity Assessment Award IEEE, 2022
  • Outstanding Physician Clinician Award American Diabetes Association, 2019
  • Director’s Citation Award for outstanding contributions to the Center for Devices and Radiological Health related to diabetes technology FDA, 2010
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Embecta Shares Study Highlighting Need for Training, Standardization in Insulin Delivery
    Embecta Shares Study Highlighting Need for Training, Standardization in Insulin DeliveryApril 2nd, 2025
  • Semaglutide May Raise Risk for Form of Optic Neuropathy in Adults with Type 2 Diabetes
    Semaglutide May Raise Risk for Form of Optic Neuropathy in Adults with Type 2 DiabetesFebruary 20th, 2025
  • Glucotrack Completes First-in-Human Continuous Blood Glucose Monitor Implant Study
    Glucotrack Completes First-in-Human Continuous Blood Glucose Monitor Implant StudyFebruary 4th, 2025
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: